Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report.
Bromocriptine
Peripartum cardiomyopathy
Preeclampsia
Journal
JA clinical reports
ISSN: 2363-9024
Titre abrégé: JA Clin Rep
Pays: Germany
ID NLM: 101682121
Informations de publication
Date de publication:
07 Jun 2019
07 Jun 2019
Historique:
received:
10
01
2019
accepted:
22
05
2019
entrez:
7
2
2020
pubmed:
7
2
2020
medline:
7
2
2020
Statut:
epublish
Résumé
Peripartum cardiomyopathy is an uncommon form of heart failure that occurs in otherwise healthy women during pregnancy or until 5 months postpartum. Here, we report a rare case where a female patient underwent cesarean section after the occurrence of preeclampsia and intrauterine fetal death, and developed peripartum cardiomyopathy following postsurgical respiratory distress. The prompt initiation of inotropic drug and bromocriptine therapy quickly restored cardiac function. The patient was a 36-year-old woman who underwent emergency cesarean section for a previous preeclampsia and an intrauterine fetal death that occurred after 24 weeks of pregnancy. In addition, the patient had an extremely low platelet count of 5000/μL on admission. She had been diagnosed as idiopathic thrombocytopenic purpura at the age of 29 years old and treated with prednisolone at 15 mg/day. Therefore, the cesarean section was performed under general anesthesia. The patient did not exhibit respiratory or hemodynamic dysfunction during surgery. However, she developed respiratory distress with sinus tachycardia after extubation and was transferred to the intensive care unit. A chest radiograph showed butterfly shadows, and transthoracic echocardiogram confirmed the reduction of left ventricle contractility (ejection fraction 20%). She was diagnosed with peripartum cardiomyopathy and treated immediately with intravenous milrinone, oral bromocriptine, and angiotensin-converting enzyme inhibitor. Respiratory and hemodynamic function improved rapidly, and the patient was moved to the general ward 2 days after surgery. Fourteen days after surgery, the patient had an ejection fraction of 57%. The patient recovered without any further complications and was discharged 24 days after surgery. A sudden case of peripartum cardiomyopathy was successfully managed by a prompt diagnosis and treatment with inotropic agents and bromocriptine.
Sections du résumé
BACKGROUND
BACKGROUND
Peripartum cardiomyopathy is an uncommon form of heart failure that occurs in otherwise healthy women during pregnancy or until 5 months postpartum. Here, we report a rare case where a female patient underwent cesarean section after the occurrence of preeclampsia and intrauterine fetal death, and developed peripartum cardiomyopathy following postsurgical respiratory distress. The prompt initiation of inotropic drug and bromocriptine therapy quickly restored cardiac function.
CASE PRESENTATION
METHODS
The patient was a 36-year-old woman who underwent emergency cesarean section for a previous preeclampsia and an intrauterine fetal death that occurred after 24 weeks of pregnancy. In addition, the patient had an extremely low platelet count of 5000/μL on admission. She had been diagnosed as idiopathic thrombocytopenic purpura at the age of 29 years old and treated with prednisolone at 15 mg/day. Therefore, the cesarean section was performed under general anesthesia. The patient did not exhibit respiratory or hemodynamic dysfunction during surgery. However, she developed respiratory distress with sinus tachycardia after extubation and was transferred to the intensive care unit. A chest radiograph showed butterfly shadows, and transthoracic echocardiogram confirmed the reduction of left ventricle contractility (ejection fraction 20%). She was diagnosed with peripartum cardiomyopathy and treated immediately with intravenous milrinone, oral bromocriptine, and angiotensin-converting enzyme inhibitor. Respiratory and hemodynamic function improved rapidly, and the patient was moved to the general ward 2 days after surgery. Fourteen days after surgery, the patient had an ejection fraction of 57%. The patient recovered without any further complications and was discharged 24 days after surgery.
CONCLUSION
CONCLUSIONS
A sudden case of peripartum cardiomyopathy was successfully managed by a prompt diagnosis and treatment with inotropic agents and bromocriptine.
Identifiants
pubmed: 32026046
doi: 10.1186/s40981-019-0256-8
pii: 10.1186/s40981-019-0256-8
pmc: PMC6966983
doi:
Types de publication
Journal Article
Langues
eng
Pagination
38Références
Circulation. 1971 Nov;44(5):964-8
pubmed: 4255967
Circulation. 2005 Apr 26;111(16):2050-5
pubmed: 15851613
Am J Cardiol. 2007 Jul 15;100(2):302-4
pubmed: 17631087
J Nippon Med Sch. 2010 Aug;77(4):226-30
pubmed: 20818143
Hypertension. 2018 Jul;72(1):24-43
pubmed: 29899139
Cell. 2007 Feb 9;128(3):589-600
pubmed: 17289576
JAMA. 2000 Mar 1;283(9):1183-8
pubmed: 10703781
Circ J. 2012;76(1):240-60
pubmed: 22185717
Eur Heart J. 2017 Sep 14;38(35):2671-2679
pubmed: 28934837
Circ J. 2011;75(8):1975-81
pubmed: 21617320
Eur J Heart Fail. 2017 Sep;19(9):1131-1141
pubmed: 28271625